Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LISA: Lactoferrin vs Antibiotics/Antifungals for Bacterial Vaginosis or Thrush
NCT05434104Recruiting
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Apr 2026
- Primary completion
- Dec 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of lactoferrin in bacterial vaginosis (BV) and vaginal candidiasis (2 arms), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoints: Acceptability of vaginal lactoferrin treatment, Adherence to treatment at 4 weeks and 2 more. Started Apr 2026; status: recruiting.
02
Drugs
lactoferrin
03
Conditions
bacterial vaginosis (BV)vaginal candidiasis
Beyond the preview
Go deeper on NCT05434104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05434104.